ANDRINI, ELISA

ANDRINI, ELISA  

Borsisti  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.02 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A. 2020-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
Bone targeting agents in patients with metastatic prostate cancer: State of the art Mollica V.; Rizzo A.; Rosellini M.; Marchetti A.; Ricci A.D.; Cimadamore A.; Scarpelli M.; Bonucc...i C.; Andrini E.; Errani C.; Santoni M.; Montironi R.; Massari F. 2021-01-01 CANCERS - 1.01 Articolo in rivista -
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. 2022-01-01 TUMORI - 1.01 Articolo in rivista -
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D....; Lamberti G. 2022-01-01 JOURNAL OF CLINICAL MEDICINE - 1.01 Articolo in rivista jcm-11-01461.pdf
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; C...asadei R.; Campana D. 2022-01-01 CANCER MEDICINE - 1.01 Articolo in rivista -
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomin...o F. 2020-01-01 CANCERS - 1.01 Articolo in rivista Lamberti_PDL1_cancers-12-03129.pdf
Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading? Ricco G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Casadei R.; Campana D.; Lambe...rti G. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-22-10629-v2.pdf
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis Mollica V.; Massari F.; Andrini E.; Rosellini M.; Marchetti A.; Nuvola G.; Tassinari E.; Lamberti... G.; Campana D. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista -
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution Di Federico A.; Andrini E.; Sisi M.; Nuvola G.; Lamberti G.; Lenzi B.; Nobili E.; Gelsomino F.; A...rdizzoni A. 2021-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib De Giglio A.; Lamberti G.; Facchinetti F.; Genova C.; Andrini E.; Dal Bello M.G.; Tiseo M.; Metro... G.; Chiari R.; Ricciuti B. 2020-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -